Skip Navigation

Cardiovascular Research 2006 71(2):352-362; doi:10.1016/j.cardiores.2006.02.004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wenzel, S.
Right arrow Articles by Schlüter, K.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wenzel, S.
Right arrow Articles by Schlüter, K.-D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Contribution of PI 3-kinase isoforms to angiotensin II- and {alpha}-adrenoceptor-mediated signalling pathways in cardiomyocytes

Sibylle Wenzel*, Yaser Abdallah, Simone Helmig, Claudia Schäfer, Hans Michael Piper and Klaus-Dieter Schlüter

Physiologisches Institut, Justus-Liebig-Universität, Aulweg 129, D-35392 Giessen, Germany

* Corresponding author. Tel.: +49 641 99 47 255; fax: +49 641 99 47 219. Email address: sibylle.wenzel{at}physiologie.med.uni-giessen.de

Objective Angiotensin II stimulation increases the formation of reactive oxygen species (ROS), the phosphorylation of p38 mitogen-activated protein kinase (MAPK), and the expression of transforming growth factor beta (TGFβ) in adult cardiomyocytes. The aim of this study was to determine the involvement of PI 3-kinase and to specify the participation of different isoforms in the angiotensin II-induced formation of ROS in comparison to the hypertrophic pathway triggered by {alpha}-adrenoceptor stimulation.

Methods Freshly isolated myocytes were used to examine formation of ROS via H2DCF fluorescence. p38 MAPK phosphorylation, p70S6-kinase phosphorylation, PI 3-kinase, and TGFβ expression were measured by Western blotting. Sense and antisense oligonucleotides were used to down-regulate diverse PI 3-kinase isoforms. Hypertrophy was measured by 14C-phenylalanine incorporation and cell volume.

Results Inhibition of PI 3-kinase by Ly294002 or wortmannin, two inhibitors, decreased formation of ROS, phosphorylation of p38 MAPK, and TGFβ expression. Down-regulation of the p110β isoform by antisense oligonucleotides inhibited the angiotensin II-induced signalling pathway but not the {alpha}-adrenoceptor-mediated hypertrophic growth of cardiomyocytes. In contrast, down-regulation of the p110{alpha} isoform decreased the {alpha}-adrenoceptor-mediated hypertrophic growth of cardiomyocytes but did not affect the angiotensin II-mediated signalling pathway.

Conclusion Thus, our study identifies an involvement of PI 3-kinase in the angiotensin II-induced formation of ROS and provides a biochemical basis for ligand-specific responses for angiotensin II and {alpha}-adrenoceptor stimulation as relates to hypertrophy.

KEYWORDS Reactive oxygen species; p38 MAPK; TGFβ; Antisense oligonucleotides; Hypertrophy


Time for primary review 30 days

* Ajay Shah, King's College, London, served as Guest Editor for this article.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Kilic, A. Bubikat, B. Gassner, H. A. Baba, and M. Kuhn
Local Actions of Atrial Natriuretic Peptide Counteract Angiotensin II Stimulated Cardiac Remodeling
Endocrinology, September 1, 2007; 148(9): 4162 - 4169.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. M. Shah and H. Sauer
Transmitting biological information using oxygen: Reactive oxygen species as signalling molecules in cardiovascular pathophysiology
Cardiovasc Res, July 15, 2006; 71(2): 191 - 194.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.